Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

New NIST clinical SRM can help in accurate CMV detection and treatment

New NIST clinical SRM can help in accurate CMV detection and treatment

Study shows how Epstein-Barr virus triggers MS

Study shows how Epstein-Barr virus triggers MS

Faulty lipid metabolism may cause MS, says forensic anthropologist

Faulty lipid metabolism may cause MS, says forensic anthropologist

Wistar to develop new drug against EBV-associated cancers

Wistar to develop new drug against EBV-associated cancers

Six UNC faculty members named AAAC fellow

Six UNC faculty members named AAAC fellow

Syndax announces data from entinostat phase 2 study on HL

Syndax announces data from entinostat phase 2 study on HL

Treatments for lymphoma with no side effects

Treatments for lymphoma with no side effects

First study to investigate risk factors for CCSVI in patients without neurological disease

First study to investigate risk factors for CCSVI in patients without neurological disease

EBV vaccine could prevent mononucleosis and cancers linked to virus

EBV vaccine could prevent mononucleosis and cancers linked to virus

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

Enrollment complete in HemaQuest HQK-1001 Phase 2 study in sickle cell disease

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

New clinical data on Bristol-Myers Squibb's NULOJIX to be presented at ESOT 2011 congress

Tiny molecule could bind to B cell EB12 receptor and prevent cancer

Tiny molecule could bind to B cell EB12 receptor and prevent cancer

DNA vaccine developer Coridon in U.S. collaboration

DNA vaccine developer Coridon in U.S. collaboration

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Chimerix initiates CMX001 Phase 2 study for prevention of adenovirus disease following HSCT

Promising results from MGH's BCG Phase I trial on type I diabetes

Promising results from MGH's BCG Phase I trial on type I diabetes

FDA approves NULOJIX

FDA approves NULOJIX

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

Epstein-Barr virus might cause multiple sclerosis, study confirms

Epstein-Barr virus might cause multiple sclerosis, study confirms